Clinical Trial: A Phase 1 Study to Evaluate Safety, Tolerability, and Drug Levels of BMS-986485 in Healthy Adult Participants

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07887763) titled 'A Phase 1 Study to Evaluate Safety, Tolerability, and Drug Levels of BMS-986485 in Healthy Adult Participants' on Oct. 14.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of the administration of a single ascending doses of BMS-986485 in healthy adult participants.

Study Start Date: Nov. 03

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: BMS-986485

Specified dose on specified days

OTHER: BMS-986485 matching placebo

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Squibb

Published by HT Digital...